KATHERINE DAVIS
TECHNOLOGY & HEALTH CARE JOURNALIST
Crain's Chicago Business
After more than a decade practicing medicine, Dr. Eve Bloomgarden is thinking of doing something different.
When Dr. Mugdha Mokashi was selecting where to complete her residency in obstetrics and gynecology, she was keenly aware of how varying state-by-state abortion laws might affect her ability to learn and practice.
Unhappy with the health insurance offered to her as a Northwestern University medical resident, Dr. Paige Hackenberger opted to get on her husband’s cheaper plan.
An unprecedented wave of CEO turnover puts some of Chicago’s top hospital chains under new leadership as they emerge from the worst of COVID-19 to face an array of financial and operational problems in an industry reshaped by the pandemic.
Being a Black woman in health care, Dr. Airica Steed knows firsthand the challenges, and sometimes downright racism and discrimination, people of color face in the industry.
Product recalls, infant deaths, federal investigations and lawsuits are turning Abbott Laboratories’ underperforming baby formula business into a major headache for the North Chicago-based medical products giant.
On a recent Monday afternoon at Planned Parenthood of Illinois’ Loop headquarters, President and CEO Jennifer Welch points to a map showing routes taken by out-of-state patients traveling to one of PPIL’s 17 clinics.
Nonprofit health system Ascension is terminating more than 110 doctors and other providers at all 10 of its Chicago-area hospitals, turning them over to a private equity-backed staffing firm while they continue to work in Ascension facilities.
After overhauling its C-suite, Chicago’s largest physicians group is shedding staff, cutting compensation and reducing services as it battles industrywide headwinds and lugs a heavy debt burden from a 2017 private-equity deal.
The moment AbbVie CEO Richard Gonzalez has spent a decade working to forestall is at hand.
A big Chicago-area doctor’s group and its private-equity backers are squaring off with a downstate hospital in a fight with potentially big implications for Illinois’ health care industry.
Abbott Laboratories is losing its lead in the U.S. baby formula market as the shutdown of an important manufacturing plant drags on.
The Chicago Department of Public Health faces a financial reckoning as the COVID-19 pandemic ebbs and federal pandemic relief funding that accounted for nearly 80% of its 2022 budget fades away over the next three years.
“I fought for this!” Ronald Jackson exclaims as he approaches the doors of what will soon be a reopened mental health clinic on Chicago’s Far South Side.
Walgreens Boots Alliance is laying off 267 employees, its second round of corporate staff reductions in recent months, Crain’s has learned.
Nestled on a leafy street and surrounded by multifamily buildings, a former hotel in Oak Park provides shelter for patients of Cook County Health with nowhere to go after receiving medical treatment. The Recuperation in a Supportive Environment Center, or RISE Center, came about during the early days of the COVID-19 pandemic, when Cook County Health was seeking ways to shelter homeless residents sick with the virus.
An ethics probe is constraining former Illinois Department of Public Health Director Dr. Ngozi Ezike in her new job as CEO of Sinai Chicago, one of the city’s largest hospital chains serving poor neighborhoods and Medicaid patients.
Amid a nationwide baby formula shortage, partly caused by a shutdown of a Michigan plant operated by North Chicago-based Abbott Laboratories, constraints on supply are affecting some neonatal intensive care units and other patients at Chicago-area hospitals.
With a nurse shortage plaguing the health care sector, Chicago hospitals are easing hiring standards, sometimes accepting associate degrees or less, rather than the previously preferred bachelor’s degrees, as they work to prop up shrinking nursing teams.